FAGRON

Fagron Expands Global Pharmaceutical Compounding Network with Strategic Acquisitions in Brazil and Hungary

- Fagron has obtained regulatory clearance for the acquisition of Vepakum in Brazil and completed the acquisition of Magilab in Hungary, expanding its global pharmaceutical compounding operations. - The Vepakum acquisition allows Fagron to enter the packaging solutions vertical through two São Paulo facilities, delivering scale benefits through joint packaging and distribution services. - Magilab strengthens Fagron's position in Hungary's hospital pharmacy compounding raw materials market, which has high compounding per capita utilization. - These strategic acquisitions support Fagron's mission to deliver personalized medicine to hospitals, pharmacies, and clinics across more than 35 countries worldwide.